MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Xarelto 2.5mg tablets (Bayer Plc).

Stability Notes

Store in airtight containers. Protect from light and maximum 8 days in MCA.

Provenance

This compatibility recommendation is derived from Natrilix SR 1.5mg tablets (Servier Laboratories Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Manerix 150mg tablets (Viatris UK Healthcare Ltd).

Stability Notes

Protect from moisture. Max 7 days in MCA.

Provenance

This compatibility recommendation is derived from Camcolit 400 modified-release tablets (Essential Pharma Ltd) and Priadel 400mg modified-release tablets (Essential Pharma M).

Stability Notes

Store in an airtight container.

Provenance

This compatibility recommendation is derived from Kemadrin 5mg tablets (Aspen Pharma Trading Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Lamictal 100mg tablets (GlaxoSmithKline UK Ltd) and Lamotrigine 100mg tablets (Milpharm Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Lamictal 50mg tablets (GlaxoSmithKline UK Ltd) and Lamotrigine 50mg tablets (Milpharm Ltd).

Stability Notes

Protect from moisture and light.

Provenance

This compatibility recommendation is derived from Livial 2.5mg tablets (Organon Pharma (UK) Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Xarelto 10mg tablets (Bayer Plc).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Xarelto 15mg tablets (Bayer Plc).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Xarelto 20mg tablets (Bayer Plc).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.